Literature DB >> 19226166

Transcriptome and proteome analysis of osteocytes treated with nitrogen-containing bisphosphonates.

Nicoletta Bivi1, Jessica Z Bereszczak, Milena Romanello, Leo A H Zeef, Daniela Delneri, Franco Quadrifoglio, Luigi Moro, Francesco L Brancia, Gianluca Tell.   

Abstract

We combined high-throughput screening of differential mRNAs with mass spectrometric characterization of proteins obtained from osteocytes untreated and treated with Risedronate. Microarray analysis revealed, upon treatment, a marked upregulation of messengers encoding zinc-proteins. MS analysis identified 84 proteins in the osteocytes proteome map. Risedronate affected the expression of 10 proteins, associated with cytoskeleton, stress-response and metabolism. Data validated using gel imaging in combination with the GLaD post digestion isotopic labeling method provide the molecular basis for understanding the role of bisphosphonates as antiapoptotic drugs for osteocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19226166     DOI: 10.1021/pr8005606

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  11 in total

Review 1.  Osteocyte regulation of bone mineral: a little give and take.

Authors:  G J Atkins; D M Findlay
Journal:  Osteoporos Int       Date:  2012-08       Impact factor: 4.507

2.  Identification of osteocyte-selective proteins.

Authors:  Dayong Guo; Andrew Keightley; Jill Guthrie; Patricia A Veno; Stephen E Harris; Lynda F Bonewald
Journal:  Proteomics       Date:  2010-10       Impact factor: 3.984

Review 3.  Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability.

Authors:  Teresita Bellido; Lilian I Plotkin
Journal:  Bone       Date:  2010-08-18       Impact factor: 4.398

Review 4.  Bisphosphonates: effects on osteoblast.

Authors:  Nicola Maruotti; Addolorata Corrado; Anna Neve; Francesco Paolo Cantatore
Journal:  Eur J Clin Pharmacol       Date:  2012-02-09       Impact factor: 2.953

5.  BRCA1 modulates the expression of hnRNPA2B1 and KHSRP.

Authors:  Manuela Santarosa; Laura Del Col; Alessandra Viel; Nicoletta Bivi; Chiara D'Ambrosio; Andrea Scaloni; Gianluca Tell; Roberta Maestro
Journal:  Cell Cycle       Date:  2010-12-01       Impact factor: 4.534

6.  Osteoblastic cell secretome: a novel role for progranulin during risedronate treatment.

Authors:  Milena Romanello; Elzbieta Piatkowska; Giulia Antoniali; Laura Cesaratto; Carlo Vascotto; Renato V Iozzo; Daniela Delneri; Francesco L Brancia
Journal:  Bone       Date:  2013-10-11       Impact factor: 4.398

7.  High bone mass in mice lacking Cx37 because of defective osteoclast differentiation.

Authors:  Rafael Pacheco-Costa; Iraj Hassan; Rejane D Reginato; Hannah M Davis; Angela Bruzzaniti; Matthew R Allen; Lilian I Plotkin
Journal:  J Biol Chem       Date:  2014-02-07       Impact factor: 5.157

Review 8.  Molecular genetic studies of gene identification for osteoporosis: the 2009 update.

Authors:  Xiang-Hong Xu; Shan-Shan Dong; Yan Guo; Tie-Lin Yang; Shu-Feng Lei; Christopher J Papasian; Ming Zhao; Hong-Wen Deng
Journal:  Endocr Rev       Date:  2010-03-31       Impact factor: 19.871

9.  Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation.

Authors:  Nicoletta Bivi; Keith W Condon; Matthew R Allen; Nathan Farlow; Giovanni Passeri; Lucas R Brun; Yumie Rhee; Teresita Bellido; Lilian I Plotkin
Journal:  J Bone Miner Res       Date:  2012-02       Impact factor: 6.741

Review 10.  Beyond gap junctions: Connexin43 and bone cell signaling.

Authors:  Lilian I Plotkin; Teresita Bellido
Journal:  Bone       Date:  2012-10-02       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.